US Patent

US10561808 — Dose counter for inhaler having an anti-reverse rotation actuator

Formulation · Assigned to Teva Pharmaceuticals Ireland · Expires 2032-01-01 · 6y remaining

Vulnerability score 31/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a dose counter for an inhaler that displays dosage information and moves incrementally in response to user input.

USPTO Abstract

A dose counter for an inhaler includes a counter display arranged to indicate dosage information, and a drive system arranged to move the counter display incrementally in a first direction from a first station to a second station in response to actuation input. A regulator is provided which is arranged to act upon the counter display at the first station to regulate motion of the counter display at the first station to incremental movements.

Drugs covered by this patent

Patent Metadata

Patent number
US10561808
Jurisdiction
US
Classification
Formulation
Expires
2032-01-01
Drug substance claim
No
Drug product claim
Yes
Assignee
Teva Pharmaceuticals Ireland
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.